Global RNAi for Therapeutic Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published: Aug, 2017 | Pages: 128 | Publisher: Data Market Research (DMR)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global RNAi for Therapeutic market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the RNAi for Therapeutic market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes RNAi for Therapeutic market by By Technology, By Molecular Form, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on RNAi for Therapeutic market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
    Alnylam Pharmaceuticals (USA)
    Arbutus Biopharma (Tekmira) (Canada)
    Arrowhead Research (USA)
    Dicerna Pharmaceuticals (USA)
    Mirna Therapeutics (USA)
    Quark Pharmaceuticals (Israel)
    RXi Pharmaceuticals (USA)
    Silence Therapeutics (Germany)
    Benitec Biopharma (Australia)
    miRagen Therapeutics (USA)
    Sylentis (Spain)
    Gradalis (USA)
    Sirnaomics (USA)
    Silenseed (Israel)
    Arcturus Therapeutics (USA)
    Arcturus Therapeutics (USA)
    Ariz Biopharma (USA)
    GeneCopoeia (USA)
    Ascletis Pharmaceuticals (USA)
    Celsion Corporation (USA)
    Astellas Pharma (USA)
    AstraZeneca (UK)
    BioSpring (Vietnam)
    Calando Pharmaceuticals (USA)
    Celgene (USA)
    Bayer Heathcare (USA)
    Biogazelle (Belgium)
    CombiMatrix (USA)
    Creative Animodel (USA)
    Ensysce Biosciences (USA)

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
RNAi for Therapeutic Market, by Technology
    siRNA
    miRNA
    shRNA
RNAi for Therapeutic Market, by Molecular Form
    Single Chain
    Double Chain

RNAi for Therapeutic Market, by Key Consumer
    Cancer
    Cardiovascular
    HBV
    Other

 Table of Contents

Global RNAi for Therapeutic Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

Chapter Two RNAi for Therapeutic Market Overview
    2.1 Market Coverage
    2.2 Global RNAi for Therapeutic Market Sales Volume Revenue and Price 2012-2017

Chapter Three RNAi for Therapeutic by Key Players 2012-2017
    3.1 Global RNAi for Therapeutic Sales Volume Market Share by Key Players 2012-2017
    3.2 Global RNAi for Therapeutic Revenue Share by Key Players 2012-2017
    3.3 Global Key Players RNAi for Therapeutic Key Product Model and Market Performance
    3.4 Global Key Players RNAi for Therapeutic Key Target Consumers and Market Performance

Chapter Four RNAi for Therapeutic by Regions 2012-2017
    4.1 Global RNAi for Therapeutic Sales Market Share by Regions 2012-2017
    4.2 Global RNAi for Therapeutic Revenue Market Share by Regions 2012-2017
    4.3 Global RNAi for Therapeutic Price by Regions 2012-2017
    4.4 North America
        4.4.1 United States
        4.4.2 Canada
    4.5 Latin America
        4.5.1 Mexico
        4.5.2 Brazil
        4.5.3 Argentina
        4.5.4 Others in Latin America
    4.6 Europe
        4.6.1 Germany
        4.6.2 United Kingdom
        4.6.3 France
        4.6.4 Italy
        4.6.5 Spain
        4.6.6 Russia
        4.6.7 Netherland
        4.6.8 Others in Europe
    4.7 Asia & Pacific
        4.7.1 China
        4.7.2 Japan
        4.7.3 India
        4.7.4 Korea
        4.7.5 Australia
        4.7.6 Southeast Asia
            4.7.6.1 Indonesia
            4.7.6.2 Thailand
            4.7.6.3 Philippines
            4.7.6.4 Vietnam
            4.7.6.5 Singapore
            4.7.6.6 Malaysia
            4.7.6.7 Others in Southeast Asia
    4.8 Africa & Middle East
        4.8.1 South Africa
        4.8.2 Egypt
        4.8.3 Turkey
        4.8.4 Saudi Arabia
        4.8.5 Iran
        4.8.6 Others in Africa & Middle East

Chapter Five RNAi for Therapeutic Market by Product Types
    5.1 RNAi for Therapeutic, by Technology 2012-2017
        5.1.1 Global RNAi for Therapeutic Sales Market Share by Technology 2012-2017
        5.1.2 Global RNAi for Therapeutic Revenue Market Share by Technology 2012-2017
        5.1.3 Global RNAi for Therapeutic Price by Technology 2012-2017
        5.1.4 siRNA
        5.1.5 miRNA
        5.1.6 shRNA
    5.2 RNAi for Therapeutic, by Molecular Form 2012-2017
        5.2.1 Global RNAi for Therapeutic Sales Market Share by Molecular Form 2012-2017
        5.2.2 Global RNAi for Therapeutic Revenue Market Share by Molecular Form 2012-2017
        5.2.3 Global RNAi for Therapeutic Price by Molecular Form 2012-2017
        5.2.4 Single Chain
        5.2.5 Double Chain

Chapter Six Global Key Players Profile
    6.1 Alnylam Pharmaceuticals (USA)
        6.1.1 Alnylam Pharmaceuticals (USA) Company Details and Competitors
        6.1.2 Alnylam Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
        6.1.3 Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.1.4 Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.2 Arbutus Biopharma (Tekmira) (Canada)
        6.2.1 Arbutus Biopharma (Tekmira) (Canada) Company Details and Competitors
        6.2.2 Arbutus Biopharma (Tekmira) (Canada) Key RNAi for Therapeutic Models and Performance
        6.2.3 Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.2.4 Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.3 Arrowhead Research (USA)
        6.3.1 Arrowhead Research (USA) Company Details and Competitors
        6.3.2 Arrowhead Research (USA) Key RNAi for Therapeutic Models and Performance
        6.3.3 Arrowhead Research (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.3.4 Arrowhead Research (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.4 Dicerna Pharmaceuticals (USA)
        6.4.1 Dicerna Pharmaceuticals (USA) Company Details and Competitors
        6.4.2 Dicerna Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
        6.4.3 Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.4.4 Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.5 Mirna Therapeutics (USA)
        6.5.1 Mirna Therapeutics (USA) Company Details and Competitors
        6.5.2 Mirna Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
        6.5.3 Mirna Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.5.4 Mirna Therapeutics (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.6 Quark Pharmaceuticals (Israel)
        6.6.1 Quark Pharmaceuticals (Israel) Company Details and Competitors
        6.6.2 Quark Pharmaceuticals (Israel) Key RNAi for Therapeutic Models and Performance
        6.6.3 Quark Pharmaceuticals (Israel) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.6.4 Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.7 RXi Pharmaceuticals (USA)
        6.7.1 RXi Pharmaceuticals (USA) Company Details and Competitors
        6.7.2 RXi Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
        6.7.3 RXi Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.7.4 RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.8 Silence Therapeutics (Germany)
        6.8.1 Silence Therapeutics (Germany) Company Details and Competitors
        6.8.2 Silence Therapeutics (Germany) Key RNAi for Therapeutic Models and Performance
        6.8.3 Silence Therapeutics (Germany) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.8.4 Silence Therapeutics (Germany) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.9 Benitec Biopharma (Australia)
        6.9.1 Benitec Biopharma (Australia) Company Details and Competitors
        6.9.2 Benitec Biopharma (Australia) Key RNAi for Therapeutic Models and Performance
        6.9.3 Benitec Biopharma (Australia) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.9.4 Benitec Biopharma (Australia) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.10 miRagen Therapeutics (USA)
        6.10.1 miRagen Therapeutics (USA) Company Details and Competitors
        6.10.2 miRagen Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
        6.10.3 miRagen Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
        6.10.4 miRagen Therapeutics (USA) RNAi for Therapeutic Sales Volume Revenue Price Cost and Gross Margin
    6.11 Sylentis (Spain)
    6.12 Gradalis (USA)
    6.13 Sirnaomics (USA)
    6.14 Silenseed (Israel)
    6.15 Arcturus Therapeutics (USA)
    6.16 Arcturus Therapeutics (USA)
    6.17 Ariz Biopharma (USA)
    6.18 GeneCopoeia (USA)
    6.19 Ascletis Pharmaceuticals (USA)
    6.20 Celsion Corporation (USA)
    6.21 Astellas Pharma (USA)
    6.22 AstraZeneca (UK)
    6.23 BioSpring (Vietnam)
    6.24 Calando Pharmaceuticals (USA)
    6.25 Celgene (USA)
    6.26 Bayer Heathcare (USA)
    6.27 Biogazelle (Belgium)
    6.28 CombiMatrix (USA)
    6.29 Creative Animodel (USA)
    6.30 Ensysce Biosciences (USA)

Chapter Seven RNAi for Therapeutic by Appliance 2012-2017
    7.1 Global RNAi for Therapeutic Sales Market Share by Appliance 2012-2017
    7.2 Cancer
    7.3 Cardiovascular
    7.4 HBV
    7.5 Other
    7.6 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
    8.1 RNAi for Therapeutic Industry Chain Structure
        8.1.1 R&D
        8.1.2 Raw Materials (Components)
        8.1.3 Manufacturing Plants
        8.1.4 Regional Trading (Import Export and Local Sales)
        8.1.5 Online Sales Channel
        8.1.6 Offline Channel
        8.1.7 End Users
    8.2 RNAi for Therapeutic Manufacturing
        8.2.1 Key Components
        8.2.2 Assembly Manufacturing
    8.3 Consumer Preference
    8.4 Behavioral Habits
    8.5 Marketing Environment

Chapter Nine Global RNAi for Therapeutic Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global RNAi for Therapeutic Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global RNAi for Therapeutic Sales (K Pcs) Forecast by Regions (2017-2022)
    9.3 Global RNAi for Therapeutic Sales (K Pcs) Forecast by Application (2017-2022)
    9.4 Global RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
    9.5 Global RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)

Chapter Ten Development Trend and Research Conclusion
    10.1 Development Trend
    10.2 Research Conclusion

List of Tables and Figures

    Table Global RNAi for Therapeutic Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global RNAi for Therapeutic Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Table Global RNAi for Therapeutic Sales Volume Market Share by Key Players (2012-2017)
    Figure Global RNAi for Therapeutic Sales Volume Market Share by Key Players 2016
    Figure Global RNAi for Therapeutic Sales Volume Market Share by Key Players 2017
    Table Global RNAi for Therapeutic Revenue (Million USD) by Key Players (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by Key Players (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by Key Players 2016
    Figure Global RNAi for Therapeutic Revenue Market Share by Key Players 2017
    Table Global Key Players Key Product Model and Market Performance
    Table Global Key Players Key Target Consumers and Market Performance
    Table Global RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Global RNAi for Therapeutic Sales Share by Regions (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Regions in 2016
    Figure Global RNAi for Therapeutic Sales Market Share by Regions in 2017
    Table Global RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by Regions (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2016
    Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2017
    Table Global RNAi for Therapeutic Price (USD/Pcs) by Regions (2012-2017)
    Table North America RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table North America RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table North America RNAi for Therapeutic Sales Volume (K Pcs) by Key Players 2012-2017
    Figure North America RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Latin America RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Latin America RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Latin America RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Europe RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Europe RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Europe RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Asia & Pacific RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East RNAi for Therapeutic Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East RNAi for Therapeutic Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East RNAi for Therapeutic Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Africa & Middle East RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global RNAi for Therapeutic Sales (K Pcs) by Technology (2012-2017)
    Table Global RNAi for Therapeutic Sales Market Share by Technology (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Technology in 2016
    Table Global RNAi for Therapeutic Revenue (Million USD) by Technology (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by Technology (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by Technology in 2016
    Table Global RNAi for Therapeutic Price (USD/Pcs) by Technology (2012-2017)
    Table Top Players of siRNA RNAi for Therapeutic Products List
    Figure Global siRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of miRNA RNAi for Therapeutic Products List
    Figure Global miRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of shRNA RNAi for Therapeutic Products List
    Figure Global shRNA RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global RNAi for Therapeutic Sales (K Pcs) by Molecular Form (2012-2017)
    Table Global RNAi for Therapeutic Sales Market Share by Molecular Form (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Molecular Form in 2016
    Table Global RNAi for Therapeutic Revenue (Million USD) by Molecular Form (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by Molecular Form (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by Molecular Form in 2016
    Table Global RNAi for Therapeutic Price (USD/Pcs) by Molecular Form (2012-2017)
    Table Top Players of Single Chain RNAi for Therapeutic Products List
    Figure Global Single Chain RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Double Chain RNAi for Therapeutic Products List
    Figure Global Double Chain RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global RNAi for Therapeutic Sales (K Pcs) by  (2012-2017)
    Table Global RNAi for Therapeutic Sales Market Share by  (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by  in 2016
    Table Global RNAi for Therapeutic Revenue (Million USD) by  (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by  (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by  in 2016
    Table Global RNAi for Therapeutic Price (USD/Pcs) by  (2012-2017)
    Table Global RNAi for Therapeutic Sales (K Pcs) by  (2012-2017)
    Table Global RNAi for Therapeutic Sales Market Share by  (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by  in 2016
    Table Global RNAi for Therapeutic Revenue (Million USD) by  (2012-2017)
    Table Global RNAi for Therapeutic Revenue Market Share by  (2012-2017)
    Figure Global RNAi for Therapeutic Revenue Market Share by  in 2016
    Table Global RNAi for Therapeutic Price (USD/Pcs) by  (2012-2017)
    Table Alnylam Pharmaceuticals (USA) Company Details and Competitors
    Table Alnylam Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
    Table Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Alnylam Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table Arbutus Biopharma (Tekmira) (Canada) Company Details and Competitors
    Table Arbutus Biopharma (Tekmira) (Canada) Key RNAi for Therapeutic Models and Performance
    Table Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Arbutus Biopharma (Tekmira) (Canada) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table Arrowhead Research (USA) Company Details and Competitors
    Table Arrowhead Research (USA) Key RNAi for Therapeutic Models and Performance
    Table Arrowhead Research (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Arrowhead Research (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Arrowhead Research (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Arrowhead Research (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure Arrowhead Research (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Arrowhead Research (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table Dicerna Pharmaceuticals (USA) Company Details and Competitors
    Table Dicerna Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
    Table Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Dicerna Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table Mirna Therapeutics (USA) Company Details and Competitors
    Table Mirna Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
    Table Mirna Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Mirna Therapeutics (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure Mirna Therapeutics (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Mirna Therapeutics (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table Quark Pharmaceuticals (Israel) Company Details and Competitors
    Table Quark Pharmaceuticals (Israel) Key RNAi for Therapeutic Models and Performance
    Table Quark Pharmaceuticals (Israel) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Quark Pharmaceuticals (Israel) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Quark Pharmaceuticals (Israel) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table RXi Pharmaceuticals (USA) Company Details and Competitors
    Table RXi Pharmaceuticals (USA) Key RNAi for Therapeutic Models and Performance
    Table RXi Pharmaceuticals (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table RXi Pharmaceuticals (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure RXi Pharmaceuticals (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table Silence Therapeutics (Germany) Company Details and Competitors
    Table Silence Therapeutics (Germany) Key RNAi for Therapeutic Models and Performance
    Table Silence Therapeutics (Germany) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Silence Therapeutics (Germany) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure Silence Therapeutics (Germany) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Silence Therapeutics (Germany) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table Benitec Biopharma (Australia) Company Details and Competitors
    Table Benitec Biopharma (Australia) Key RNAi for Therapeutic Models and Performance
    Table Benitec Biopharma (Australia) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table Benitec Biopharma (Australia) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure Benitec Biopharma (Australia) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Benitec Biopharma (Australia) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table miRagen Therapeutics (USA) Company Details and Competitors
    Table miRagen Therapeutics (USA) Key RNAi for Therapeutic Models and Performance
    Table miRagen Therapeutics (USA) RNAi for Therapeutic Business SWOT Analysis and Forecast
    Table miRagen Therapeutics (USA) RNAi for Therapeutic Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales Market Share (%) in Global (2012-2017)
    Figure miRagen Therapeutics (USA) RNAi for Therapeutic Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure miRagen Therapeutics (USA) RNAi for Therapeutic Revenue Market Share (%) in Global (2012-2017)
    Table Sylentis (Spain) Company Details and Competitors
    Table Gradalis (USA) Company Details and Competitors
    Table Sirnaomics (USA) Company Details and Competitors
    Table Silenseed (Israel) Company Details and Competitors
    Table Arcturus Therapeutics (USA) Company Details and Competitors
    Table Arcturus Therapeutics (USA) Company Details and Competitors
    Table Ariz Biopharma (USA) Company Details and Competitors
    Table GeneCopoeia (USA) Company Details and Competitors
    Table Ascletis Pharmaceuticals (USA) Company Details and Competitors
    Table Celsion Corporation (USA) Company Details and Competitors
    Table Astellas Pharma (USA) Company Details and Competitors
    Table AstraZeneca (UK) Company Details and Competitors
    Table BioSpring (Vietnam) Company Details and Competitors
    Table Calando Pharmaceuticals (USA) Company Details and Competitors
    Table Celgene (USA) Company Details and Competitors
    Table Bayer Heathcare (USA) Company Details and Competitors
    Table Biogazelle (Belgium) Company Details and Competitors
    Table CombiMatrix (USA) Company Details and Competitors
    Table Creative Animodel (USA) Company Details and Competitors
    Table Ensysce Biosciences (USA) Company Details and Competitors
    Table Global RNAi for Therapeutic Sales (K Pcs) by Appliance (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Appliance (2012-2017)
    Figure Global RNAi for Therapeutic Sales Market Share by Appliance in 2016
    Figure Global Cancer RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Cardiovascular RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global HBV RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Other RNAi for Therapeutic Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global RNAi for Therapeutic Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global RNAi for Therapeutic Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global RNAi for Therapeutic Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Share Forecast by Regions in 2022
    Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Application in 2022
    Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
    Figure Global RNAi for Therapeutic Sales (K Pcs) Forecast by Technology (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Technology in 2022
    Table Global RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)
    Figure Global RNAi for Therapeutic Sales (K Pcs) Forecast by Molecular Form (2017-2022)
    Figure Global RNAi for Therapeutic Sales Volume Market Share Forecast by Molecular Form in 2022